Beyond Embryo Politics
By Emily Galpern,
The Women's Health Activist: Newsletter of the National Women's Health Network
| 04. 30. 2006
Women's Health and Dignity in Stem Cell Research
May / June 2006
"Which comes first-the egg or the cure?" asks an advertisement enticing young women to provide their eggs for stem cell research. The ad lists several diseases and asserts that "It could happen to you or your loved one", and encourages the reader to: "Let your eggs be part of the cure." These slogans mark the re-entry of U.S. scientists into what many see as a global stem cell race. The downfall of disgraced South Korean scientist Hwang Woo-suk, who fabricated data to support his claim that he harvested stem cells from a cloned human embryo, has prompted scientists to scramble to truly be "the first."
The hype around stem cell research and the resulting media attention have raised public hopes that research will soon lead to cures for chronic diseases such as diabetes and Parkinson's. These hopes overshadow serious risks associated with one approach to stem cell research that has been receiving increased attention from scientists. This technique, somatic cell nuclear transfer (SCNT) or "research cloning", raises serious concerns because it requires a huge number of...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Elise Kinsella, ABC News | 06.15.2025
When *Sarah and her partner needed fertility testing, it was Monash IVF that the pair turned to.
"Having a quick browse online, Monash IVF was one of the most prominent ones that came up on Google search and after contacting...
By Tory Shepherd, The Guardian | 06.13.2025
IVF is “big business” and experts are concerned about conflicts of interest between profit-making and helping families have children.
Monash IVF’s second embryo bungle has sparked renewed scrutiny on the IVF industry as a whole amid calls for national regulation...